Abstract: A method and chemical composition for modifying and dissolving atherosclerotic plaques formed in a patient's blood vessels is provided. A chemical composition comprising one or more of an organic substance, an inorganic substance, and a bioactive substance is administered at sites of the plaques. The chemical composition comprises one or more of d-limonene, propylene glycol, octanoic acid, 2-octane, glycerine, acetylsalicylic acid, acetic acid, omega-3 fatty acids, ethanol, methanol, ezetimibe, rosuvastatin, resveratrol, lactic acid, gluconic acid, chloroform, carbon disulfide, dichloromethane, toluene, lauryldimethyl hydroxysultaine, and any combination thereof. The chemical composition enables modification of plaques by altering their composition. The modification comprises partial dissolution, complete dissolution, or elimination of the plaques, and makes the plaques amenable to different forms of plaque treatment. The modified plaques are eliminated from the patient's body.

Abstract: A system and method is provided for detection, forewarning, and rapid therapeutic treatment of a patient's ischemic and arrhythmic heart condition, congestive heart failure, respiratory failure, etc. The system comprises a chest casing of a form fitting material. The inner surface of the chest casing comprises electrocardiogram sensor electrodes, auscultation sensors, impedance sensor electrodes, etc. The electrocardiogram sensor electrodes detect abnormal electrocardiogram signals. The auscultation sensors record internal sounds at predefined cardiac and respiratory auscultation sensor points. The impedance sensor electrodes measure thoracic impedance across two or more points on the chest wall. A control unit is connected to the sensors for collecting and processing patient information. The control unit transmits the processed patient information to an external monitoring station.

Abstract: A method and chemical composition for modifying and dissolving atherosclerotic plaques formed in blood vessels of a patient is provided. The chemical composition comprising one or more of an organic substance, an inorganic substance, and a bioactive product is administered at sites of the plaques formed in the patient's blood vessels. The chemical composition comprises, for example, one or more of d-limonene, propylene glycol, octanic acid, 2-octane, and glycerine. The chemical composition enables modification of the plaques by altering composition of the plaques. The modification comprises partial dissolution, complete dissolution or elimination of the plaques. The modification makes the plaques amenable to different forms of plaque treatment, for example, balloon angioplasty, stenting, atherectomy, etc. The modified plaques are eliminated from the body of the patient.

Abstract: A catheter assembly configurable to multiple shapes is provided. The catheter assembly comprises a detachable, interchangeable and configurable outer catheter and a detachable, interchangeable and flexible inner catheter. The shape of the outer catheter is configured to facilitate guiding of the inner catheter into an inner cavity of a patient's anatomy. The inner catheter is generally coaxial with the outer catheter. The second flexible distal end of the inner catheter enables the inner catheter to engage the inner cavity of the patient's anatomy. A locking element is provided for securing the inner catheter to the outer catheter, when the second flexible distal end of the inner catheter engages the inner cavity of the patient's anatomy to allow equipment or material to be introduced into the inner cavity. The catheter assembly is configured and manipulated to fit inner cavities of multiple anatomies for enabling a medical practitioner to perform medical procedures.